Suzanne Jackowski

Title: Suzanne Jackowski: Innovator in Metabolic and Neurologic Disorders

Introduction

Suzanne Jackowski is a prominent inventor based in Bartlett, TN (US), known for her significant contributions to the field of metabolic and neurologic disorders. With a total of three patents to her name, she has made strides in developing innovative treatments that address critical health issues.

Latest Patents

One of her latest patents focuses on small molecule modulators of pantothenate kinases. This invention relates to chemical compounds that modulate pantothenate kinase (PanK) activity for the treatment of metabolic disorders, such as type II diabetes and neurologic disorders like pantothenate kinase-associated neurodegeneration. The patent outlines pharmaceutical compositions containing these compounds and their applications in treatment. Another notable patent involves methods of treating disorders associated with coenzyme A reduction, elevation, sequestration, toxicity, or redistribution (CASTOR) disease. This includes addressing defects in fatty acid oxidation enzymes and other related conditions through small molecule modulators of CoA levels.

Career Highlights

Throughout her career, Suzanne has worked with esteemed organizations, including St. Jude Children's Research Hospital and Coa Therapeutics, Inc. Her work in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Suzanne has collaborated with notable colleagues, including Richard Edward Lee and Charles O Rock. These partnerships have further enhanced her research and development efforts in the medical field.

Conclusion

Suzanne Jackowski's innovative work in the treatment of metabolic and neurologic disorders showcases her dedication to improving health outcomes through scientific advancements. Her patents reflect her commitment to addressing complex medical challenges and her impact on the field of biomedical research.